SAVARA PHARMACEUTICALS

Savara is an orphan lung disease company. Savara’s pipeline comprises Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF, in Phase 3 development for autoimmune pulmonary alveolar proteinosis, or aPAP, in Phase 2a development for nontuberculous mycobacteria, or NTM, lung infection, and in preparation for Phase 2a development in cystic fibrosis, or CF, affected individuals with chronic NTM lung infection; and AeroVanc, a Phase 3 stage inhaled vancomycin for treatme... nt of persistent methicillin resistant staphylococcus aureus, or MRSA, lung infection in CF. Savara’s strategy involves expanding its pipeline of potentially best-in-class products through indication expansion, strategic development partnerships and product acquisitions, with the goal of becoming a leading company in its field. The most recent acquisition is aerosolized amikacin/fosfomycin, a Phase 2 ready, proprietary combination antibiotic, which has demonstrated potent and broad-spectrum antibacterial activity against highly drug resistant pathogens. Savara’s management team has significant experience in orphan drug development and pulmonary medicine, identifying unmet needs, developing and acquiring new product candidates, and effectively advancing them to approvals and commercialization.

#SimilarOrganizations #People #Financial #Website #More

SAVARA PHARMACEUTICALS

Social Links:

Twitter

Industry:

Biopharma Biotechnology Pharmaceutical

Founded:

2007-01-01

Address:

Austin, Texas, United States

Country:

United States

Website Url:

http://www.savarapharma.com

Total Employee:

11+

Status:

Active

Contact:

+1 (512) 961-1891

Email Addresses:

[email protected]

Total Funding:

287.6 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Content Delivery Network Font Awesome

Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

aprecia-pharmaceuticals-logo

Aprecia Pharmaceuticals

Aprecia Pharmaceuticals develops precision drug delivery systems and products.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

sirnaomics-logo

Sirnaomics

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.

Current Advisors List

ricky-sun_image

Ricky Sun Board Of Directors @ Savara Pharmaceuticals
Board_member

nevan-elam_image

Nevan Elam Board of Directors @ Savara Pharmaceuticals
Board_member

not_available_image

Joseph McCracken Board Member @ Savara Pharmaceuticals
Board_member

Current Employees Featured

dave-lowrance_image

Dave Lowrance
Dave Lowrance Chief Financial Officer @ Savara Pharmaceuticals
Chief Financial Officer
2016-11-01

john-k-john_image

John K. John
John K. John Vice President & Head of Quality @ Savara Pharmaceuticals
Vice President & Head of Quality

kenny-frazier_image

Kenny Frazier
Kenny Frazier Vice President of Clinical Development @ Savara Pharmaceuticals
Vice President of Clinical Development
2015-05-01

mike-ciesla_image

Mike Ciesla
Mike Ciesla VP Finance and Director of SEC Reporting @ Savara Pharmaceuticals
VP Finance and Director of SEC Reporting

taneli-jouhikainen_image

Taneli Jouhikainen
Taneli Jouhikainen COO & President @ Savara Pharmaceuticals
COO & President
2009-10-01

matthew-pauls_image

Matthew Pauls
Matthew Pauls Chair and Chief Executive Officer @ Savara Pharmaceuticals
Chair and Chief Executive Officer
2020-12-01

peter-ginsberg_image

Peter Ginsberg
Peter Ginsberg Vice President & Business Development @ Savara Pharmaceuticals
Vice President & Business Development

anne-erickson_image

Anne Erickson
Anne Erickson SVP and Chief of Staff @ Savara Pharmaceuticals
SVP and Chief of Staff
2018-10-01

john-lord_image

John Lord
John Lord Vice President & Pharmaceutical Development @ Savara Pharmaceuticals
Vice President & Pharmaceutical Development
2010-12-01

badrul-chowdhury_image

Badrul Chowdhury
Badrul Chowdhury Chief Medical Officer @ Savara Pharmaceuticals
Chief Medical Officer
2019-11-01

Founder

chris-marich_image

Chris Marich

rob-neville_image

Rob Neville

Stock Details

Company's stock symbol is NASDAQ:SVRA

Acquisitions List

Date	Company	Article	Price
2016-06-21	Serendex Pharmaceuticals	Serendex Pharmaceuticals acquired by Savara Pharmaceuticals	N/A

Investors List

silicon-valley-bank_image

Official Site Inspections

http://www.savarapharma.com Semrush global rank: 4.85 M Semrush visits lastest month: 1.84 K

Host Informations
Whois Informations

Loading ...